With an emphasis on depressive disorders, this industry focused forum will allow you to explore novel targets and mechanisms of action, address factors for mitigating and eliminating risk in clinical trials and evaluate the preclinical and clinical biomarker landscape to more robustly translate preclinical results in the clinic.

Join your peers at NPD to be part of the cross-industry discussion on latest developments, insights and science to elevate clinically effective neuropsychiatric therapeutic pipelines.

Schedule a Meeting with VeraSci for NPD 2019

  • :